Overcoming resistance to immune checkpoint inhibitors in NSCLC Published 2023-02-23 Download video MP4 360p Download video MP4 720p Recommendations 02:14 Managing renal cell carcinoma after progressing on checkpoint inhibitors 01:24 The emerging benefits of adjuvant checkpoint inhibition in RCC 02:44 The role of radiation in managing high-risk localized prostate cancer 00:52 How can regular exercise benefit patients with cancer? 01:52 Side Effects of Oxaliplatin 03:54 PAPMET2: cabozantinib with or without atezolizumab in PRCC 03:53 FolFox Chemo Side Effects | The Big C in Me 03:47 Salvage radiotherapy in biochemically recurrent prostate cancer 03:41 ASCO GU 2024 highlights: BRCAAway, CONTACT-2 and KEYNOTE-564 03:09 How can radiotherapy make prostate cancer more immunogenic? 05:45 HER2-Positive Breast Cancer: A Paradigm Shift in Diagnosis and Therapy 02:06 Variability in genomic testing among prostate cancer care providers 01:06 Predicting pelvic lymph node involvement in MIBC with FDG-PET 03:04 Evaluating the role of radiotherapy in primary and metastatic RCC 01:58 Management of urothelial cancer with combination immunotherapies 02:24 SPPORT: ADT and salvage radiotherapy in prostate cancer 02:23 Which patients with prostate cancer benefit from radiotherapy and hormonal therapy? 01:41 Current and emerging applications for ctDNA analysis in prostate cancer 02:15 The benefits of determining front-line therapy in NSCLC with liquid biopsies 01:09 What role does FDG-PET have in managing bladder cancer? Similar videos 01:46 Predicting response to checkpoint inhibitors and overcoming resistance in lung cancers 01:23 Mechanisms resulting in resistance to checkpoint inhibitors in NSCLC 02:07 Immune Checkpoint Inhibitors, The Next Generation Cancer Therapy - Creative Biolabs 01:20 Resistance to immune checkpoint blockade in patients with cSCC 01:07 Checkpoint inhibitors for lung cancer: combating resistance 02:29 Overcoming resistance to immunotherapy 00:43 Dr. Jackman on Overcoming Resistance to EGFR Inhibitors in Lung Cancer 02:53 Overcoming resistance to IO with sitravatinib + tocilizumab in patients with lung cancer 02:05 Improving responses to immunotherapy in NSCLC 1:01:21 UofL Dept. of Medicine Grand Rounds: Dr. Jason Chesney 07:54 Immune Checkpoint Inhibitors in NSCLC 1:01:54 "Immune Checkpoint Blockade in Cancer Therapy" by Dr. Jim Allison 03:46 Overcoming Resistance in ROS1+, RET+, or BRAF+ NSCLC - Lung Cancer OncTalk 2022 44:15 June 7, 2021 | Investigating Mechanisms of Response & Resistance to Immune Checkpoint Therapy 02:47 Mechanisms of acquired resistance against immunotherapy 05:55 Checkpoint inhibitor resistance in lung cancer 03:18 Immune checkpoint inhibitors and combination strategies for patients with gastric cancer 01:45 Mechanisms of resistance to checkpoint inhibitors in melanoma 00:55 Enhancing the efficacy of immune checkpoint inhibitors in CRC More results